juniper88’s details
| symbol | subject | date & time | rating |
|
|
I voted yesterday. I am just a small time retail so I don't know how much of a difference that it will make. But about 70% of this company is owned by retail investors like us. I voted my 100K shares exactly as you. |
5/10/2013 8:40:28 AM |
|
|
|
Pommier had grandiose dreams and hired a glorified secretary. About $10 million wasted. We could easily have run a phase I trial for the new compound with that money. And still we have no idea what the real reason was for getting rid of Huss. ... |
5/7/2013 2:36:01 PM |
|
|
|
Currently, there is $17.9 Million left in cash, or just more than 29 cents/share. Yet TH is trading at 27.5 cents/share. Doesn't that tell you something about what confidence the street has in this management. |
4/11/2013 10:29:16 AM |
1 |
|
|
He was very short also. This is an oppertunity to get on the analysts' good side. Instead he just answered with one word "No." I think he will be CEO for a while. It is not as if we can afford anyone else. Did I hear right that w... |
4/11/2013 9:06:53 AM |
|
|
|
And just when you think things cannot get worse... What a bunch of idiots. I am still completely baffled why someone like Graham would want to be associated with Thera. What else can possibly go wrong? |
4/11/2013 8:14:03 AM |
|
|
|
Sorry, April 1 was last week. I don't get it. Why would someone of her calibre and experience want the come onto our sinking ship? I welcome the move, but I don't understand why she would do this. |
4/9/2013 8:21:26 AM |
|
|
|
Just put 1 +1 together and you get 2. Cleaning up the lease agreement and now the terminantion of the Ferrer agreement makes Thera a much more likely takeover target. I have to say so far Tanguay has gotten a lot more done than Huss. |
4/8/2013 7:55:59 AM |
|
|
|
I suppose there is nothing it the Serono contract either as to how much advertising dollars the should be spending to promote Egrifta. The realit is that Thera again has become a binary biotech company. If Brazil rejects then they will only have ... |
3/15/2013 9:47:07 AM |
3 |
|
|
Up 3% month over month but down year over year for the same month. Serono incapable/unwilling to sell Egrifta. |
3/14/2013 1:37:38 PM |
|
|
|
In my opinion, and I have no proof, Serono is playing hardball. You will not see any rise in Egrifta U.S. sales until Serono has taken our shares. I do believe Serono will offer a 100% premium (sold for 70 to 80 cents/share) to make it look lik... |
3/13/2013 6:57:59 AM |
4 |
|
No additional content to display.
Stockhouse.com: Taking
it to the street
